INSM News and Press, Insmed Inc. From 05/07/24

Insmed To Present at the BofA Securities Health Care Conference 2024 PR Newswire BRIDGEWATER, N.J. , May 7, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with seriou...

Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 PR Newswire BRIDGEWATER, N.J. , April 25, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives o...

2024-04-23 11:37:17 ET Summary Spero Therapeutics, Inc. has continued to build and advance its pipeline over the past several months and is now on the verge of generating landmark data with multi-bagger potential. Spero has excellent downside protection and additional upside from ...

2024-04-22 11:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-09 11:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. We are seeing underlyi...

2024-04-02 15:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-01 08:53:49 ET More on the markets My Current View Of The Market: April 2024 Edition (Technical Analysis) SPY: Potential, Yes, But Risks Ahead Too Where This Market Is Going (Technical Analysis) Investors are sellers of fund assets for the second cons...

2024-04-01 07:30:05 ET Wells Fargo analyst issues OVERWEIGHT recommendation for INSM on April 1, 2024 05:51AM ET. The previous analyst recommendation was Overweight. INSM was trading at $27.13 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2024-04-01 07:00:05 ET Tiago Fauth from Wells Fargo issued a price target of $55.00 for INSM on 2024-04-01 05:51:00. The adjusted price target was set to $55.00. At the time of the announcement, INSM was trading at $27.13. The overall price target consensus is at $56.00 ...

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference PR Newswire — Additional Data from ARISE Study Evaluating the Impact of ARIKAYCE on Microbiologic Outcomes in Patients with Newly Diagnosed or...